Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10015979 Isotopically modified compounds and their use as food supplements

Patent 10015979 was granted and assigned to Retrotope Inc. on July, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 9 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12110272 Deuterated tryptamine derivatives and methods of use
0
Edits on 17 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 17 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11958807 Deuterated tryptamine derivatives and methods of use
0
Edits on 8 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 8 Dec, 2023
Edits made to:
Article (+224 characters)
Article

Patent abstract

A nutrient composition comprises an essential nutrient in which at least one exchangeable H atom is 2H and/or at least one C atom is 13C. The nutrient is thus protected from, inter alia, active oxygen species.

Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11834410 Deuterated tryptamine derivatives and methods of use
0
Edits on 1 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 1 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Mikhail Sergeevich Shchepinov0
Edits on 7 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11746088 Deuterated tryptamine derivatives and methods of use
Edits on 26 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Retrotope Inc.
Retrotope Inc.
0
Current Assignee
Retrotope Inc.
Retrotope Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
100159790
Date of Patent
July 10, 2018
0
Patent Application Number
154469220
Date Filed
March 1, 2017
0
Patent Citations Received
‌
US Patent 11242318 Deuterated tryptamine derivatives and methods of use
0
Patent Primary Examiner
‌
Benjamin J Packard
0
Edits on 25 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Mar, 2023
Edits on 22 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Edits on 9 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11242318 Deuterated tryptamine derivatives and methods of use
Edits on 21 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 21 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10015979 Isotopically modified compounds and their use as food supplements

Infobox
Is a
Patent
Patent
Patent applicant
Retrotope Inc.
Retrotope Inc.
Current assignee
Retrotope Inc.
Retrotope Inc.
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10015979
Date of patent
July 10, 2018
Patent application number
15446922
Date Filed
March 1, 2017
Patent primary examiner
‌
Benjamin J Packard

Find more entities like US Patent 10015979 Isotopically modified compounds and their use as food supplements

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.